Company Filing History:
Years Active: 1994-1995
Title: Innovations by Richard D. Medwid
Introduction
Richard D. Medwid is an accomplished inventor based in Fort Collins, Colorado. He has made significant contributions to the field of biotechnology, particularly in the production of carotenoids and zeaxanthin. With a total of two patents to his name, Medwid's work has implications for various applications, including health and nutrition.
Latest Patents
Medwid's latest patents include a culture for the production of xanthophylls, specifically utilizing Nospongiococcum excentricum ATCC 40335 and its mutants. This culture is notable for its ability to achieve a dry cell weight xanthophyll content of at least about 0.65% and can grow to a cell density exceeding 40 grams per liter. Additionally, he has developed a process for producing zeaxanthin through the mutation of algal microorganisms. This process involves selecting a microorganism capable of producing zeaxanthin, culturing it in an effective medium, and recovering the zeaxanthin produced. His inventions also encompass formulations containing zeaxanthin, which can enhance pigmentation and mitigate damage from reactive oxygen species and phototoxic molecules.
Career Highlights
Richard D. Medwid is currently associated with Universal Foods Corporation, where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in health and nutrition, particularly in enhancing the quality of food products.
Collaborations
Medwid has collaborated with notable colleagues, including Steve A. Orndorff and Elizabeth A. Campbell. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Richard D. Medwid's contributions to biotechnology through his innovative patents highlight his role as a significant inventor in the field. His work not only advances scientific knowledge but also has practical applications that can benefit various industries.